Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Issuer Symbol
-
ALZN on Nasdaq
Milton C. Ault III - trading volume in the past year for Alzamend Neuro, Inc.
Holdings reported by Milton C. Ault III for Alzamend Neuro, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
11,068 |
$24,792 |
$2.24 |
23 Dec 2025 |
By Ault Life Sciences, Inc. |
|
|
| Common Stock |
8,260 |
$18,502 |
$2.24 |
23 Dec 2025 |
By Ault Lending, LLC |
|
|
| Common Stock |
61 |
$136 |
$2.24 |
23 Dec 2025 |
By Ault Life Sciences Fund, LLC |
|
|
| Common Stock |
0 |
$0 |
$2.07 |
23 Dec 2025 |
Direct |
|
|
| Series B Convertible Preferred Stock |
0 |
$0 |
$1000.00 |
08 Oct 2025 |
By Ault Lending, LLC |
Common Stock |
|
| Common Stock Purchase Warrants |
1,111 |
|
|
08 Oct 2025 |
By Ault Lending, LLC |
Common Stock |
|
| Common Stock Purchase Warrants |
12 |
|
|
30 Jul 2025 |
By Hyperscale Data, Inc. |
Common Stock |
|
Transactions reported by Milton C. Ault III for Alzamend Neuro, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.